arrow
返回
D

Didier Cupissol

universite de montpellier

46H指数
315论文数
1.4W被引数
收录论文 59
发表时间
Adapted EXTREME regimen in the first-line treatment of fit older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, singlearm, phase 2 trial
err2024-06-01
err2
errOAAI
errGuigay, Joel; Le Caer, Herve; Ferrand, Francois-Regis; Geoffrois, Lionel; Saada-Bouzid, Esma; Fayette, Jerome; Sire, Christian; Cupissol, Didier; Blot, Emmanuel; Guillet, Pierre; Pavillet, Julien; Bozec, Laurence; Capitain, Olivier; Rolland, Frederic; Debourdeau, Philippe; Pointreau, Yoann; Falandry, Claire; Lopez, Stephane; Coutte, Alexandre; Chatellier, Thierry; Dalloz, Pierre; Ortholan, Cecile; Michel, Cecile; Lacas, Benjamin; Cheurfa, Nadir; Schwob, Dominique; Bourhis, Jean; Mertens, Cecile; Auperin, Anne
err分享
err收藏
Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3trial
err2024-03-01
err0
errOAAI
errGuigay, Joel; Ortholan, Cecile; Vansteene, Damien; Cupissol, Didier; Even, Caroline; Kaminsky, Marie -Christine; Sire, Christian; Blot, Emmanuel; Debourdeau, Philippe; Bozec, Laurence; Saada-Bouzid, Esma; Fayette, Jerome; Dalloz, Pierre; Pointreau, Yoann; Le Caer, Herve; Falandry, Claire; Digue, Laurence; Braccini, Antoine; Lopez, Stephane; Guillet, Pierre; Michel, Cecile; Cheurfa, Nadir; Schwob, Dominique; Bourhis, Jean; Mertens, Cecile; Auperin, Anne
err分享
err收藏
Monalizumab, cetuximab and durvalumab in first-line treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): A phase II trial
err2021-12-01
err11
errOAAI
errColevas, D. A.; Misiukiewicz, K.; Pearson, A. T.; Fayette, J.; Bauman, J. R.; Cupissol, D.; Saada-Bouzid, E.; Adkins, D. R.; Marie, D. B.; Cornen, S. L.; Andre, P.; Carrette, F.; Rotolo, F.; Boyer Chammard, A.; Cohen, R. B.
err分享
err收藏
Results of the randomized, placebo (PL)-controlled phase II study evaluating the efficacy and safety of regorafenib (REGO) in patients (pts) with relapsed advanced or metastatic chordoma, on behalf of the French Sarcoma Group (FSG) and Unicancer
err2021-09-01
err2
errOAAI
errDuffaud, F.; Chabaud, S.; Chevreau, C. M.; Italiano, A.; Perrin, C.; Isambert, N.; Piperno-Neumann, S.; Saada-Bouzid, E.; Bertucci, F.; Cupissol, D.; Kalbacher, E.; Narciso, B.; Schiffler, C.; Carvalho, N. de Sousa; Monard, L.; Bouvier, C.; Vidal, V.; Blay, J-Y.; Mir, O.
err分享
err收藏
LMS-04 study: A randomised, multicenter, phase III study comparing doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin in non-progressive patients as first-line therapy, in patients with metastatic or unresectable leiomyosarcoma - A French Sarcoma Group study
err2021-09-01
err11
errOAAI
errPautier, P.; Italiano, A.; Piperno-Neumann, S.; Chevreau, C. M.; Penel, N.; Cupissol, D.; Rouquette, P. Boudou; Bertucci, F.; Balleyguier, C.; Lebrun-Ly, V.; Blay, J-Y.; Kalbacher, E.; Delcambre, C.; Bompas, E.; Collard, O.; Isambert, N.; Guillemet, C.; Rios, M.; Sundqvist, M.; Duffaud, F.
err分享
err收藏
Impact of sarcopenia (S) on efficacy and toxicity of nivolumab (N) in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) in TOPNIVO (T) study
err2021-09-01
err0
errOAAI
errMuratori, L.; Texier, M.; Mayache-Badis, L.; Bidault, F.; Iacob, M.; Daste, A.; Fayette, J.; Lefebvre, G.; Saada-Bouzid, E.; Zanetta, S.; Toullec, C.; Cupissol, D.; Salas, S.; Kaminsky-Forrett, M-C.; Johnson, A. C.; Ferrand, F. R.; Auperin, A.; Guigay, J.; Raynard, B.; Even, C.
err分享
err收藏
A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery
err2021-08-01
err18
errOAAI
errPautier, P.; Floquet, A.; Chevreau, C.; Penel, N.; Guillemet, C.; Delcambre, C.; Cupissol, D.; Selle, F.; Isambert, N.; Piperno-Neumann, S.; Saada-Bouzid, E.; Bertucci, F.; Bompas, E.; Alexandre, J.; Collard, O.; Lebrun-Ly, V.; Soulier, P.; Toulmonde, M.; Le Cesne, A.; Lacas, B.; Duffaud, F.
err分享
err收藏
A randomized phase III trial comparing trabectedin to best supportive care in patients with pre-treated soft tissue sarcoma: T-SAR, a French Sarcoma Group trial一项比较trabectedin与最佳支持治疗的软组织肉瘤患者的随机III期试验: t-sar,法国肉瘤组试验
err2021-08-01
err20
errOAAI
errLe Cesne, A.; Blay, J-Y; Cupissol, D.; Italiano, A.; Delcambre, C.; Penel, N.; Isambert, N.; Chevreau, C.; Bompas, E.; Bertucci, F.; Chaigneau, L.; Piperno-Neumann, S.; Salas, S.; Rios, M.; Guillemet, C.; Bay, J-O; Ray-Coquard, I; Haddag, L.; Bonastre, J.; Kapso, R.; Fraslin, A.; Bouvet, N.; Mir, O.; Foulon, S.
err分享
err收藏
Monalizumab in combination with cetuximab post platinum and anti-PD-(L)1 in patients with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Updated results from a phase II trial
err2020-12-01
err3
errOAAI
errFayette, J.; Bauman, J.; Salas, S.; Colevas, D.; Even, C.; Cupissol, D.; Posner, M. R.; Lefebvre, G.; Saada-Bouzid, E.; Bernadach, M.; Seiwert, T.; Pearson, A.; Messouak, S.; Cornen, S. L.; Andre, P.; Rotolo, F.; Boyer-Chammard, A.; Cohen, R. B.
err分享
err收藏
A double-blind phase III trial of immunomodulating nutritional formula during adjuvant chemoradiotherapy in head and neck cancer patients: IMPATOX
err2020-12-01
err24
errOAAI
errBoisselier, Pierre; Kaminsky, Marie-Christine; Thezenas, Simon; Gallocher, Olivier; Lavau-Denes, Sandrine; Garcia-Ramirez, Muriel; Alfonsi, Marc; Cupissol, Didier; de Forges, Helene; Janiszewski, Chloe; Geoffrois, Lionnel; Sire, Christian; Senesse, Pierre
err分享
err收藏
Germinal immunogenetics and response to nivolumab in recurrent/metastatic head and neck squamous cell carcinoma (RM HNSCC) patients (pts): TopNIVO ancillary study
err2020-09-01
err0
errOAAI
errSaada, E. B.; Koudou, Y.; Daste, A.; Fayette, J.; Lefebvre, G.; Zanetta, S.; Toullec, C.; Cupissol, D.; Salas, S.; Kaminsky-Forrett, M-C.; Johnson, A. C.; Vauleon, E.; Ebran, N.; Schmidt, M.; Texier, M.; Peyrade, F.; Milano, G.; Guigay, J.; Even, C.; Etienne-Grimaldi, M-C.
err分享
err收藏
MEDINDUCTION: Phase I trial evaluating the safety of durvalumab in combination with docetaxel, cisplatin and 5-FU (DCF) as induction therapy for locally advanced squamous cell carcinoma of the head and neck (SCCHN)
err2020-09-01
err1
errOAAI
errEven, C.; Texier, M.; Le Tourneau, C.; Bahleda, R.; Borcoman, E.; Vinches, M.; Toussaint, P.; Marabelle, A.; Breuskin, I.; Cupissol, D.; Fayette, J.
err分享
err收藏
A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study)
err2020-01-01
err25
PREAI
errPautier, P.; Penel, N.; Ray-Coquard, I.; Italiano, A.; Bompas, E.; Delcambre, C.; Bay, J. -O.; Bertucci, F.; Delaye, J.; Chevreau, C.; Cupissol, D.; Bozec, L.; Eymard, J. -C.; Saada, E.; Isambert, N.; Guillemet, C.; Rios, M.; Piperno-Neumann, S.; Chenuc, G.; Duffaud, F.
err分享
err收藏
Circulating Tumor Cells as a Prognostic Factor in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: The CIRCUTEC Prospective Study
err2019-10-01
err40
errOAAI
errGarrel, Renaud; Mazel, Martine; Perriard, Francoise; Vinches, Marie; Cayrefourcq, Laure; Guigay, Joel; Digue, Laurence; Aubry, Karine; Alfonsi, Marc; Delord, Jean-Pierre; Lallemant, Benjamin; Even, Caroline; Daures, Jean-Pierre; Landais, Paul; Cupissol, Didier; Alix-Panabieres, Catherine
err分享
err收藏
Afatinib as second-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Subgroup analyses of treatment adherence, safety and mode of afatinib administration in the LUX-Head and Neck 1 trial
err2019-10-01
err6
PREAI
errHaddad, Robert; Guigay, Joel; Keilholz, Ulrich; Clement, Paul M.; Fayette, Jerome; Viana, Luciano de Souza; Rolland, Frederic; Cupissol, Didier; Geoffrois, Lionnel; Kornek, Gabriela; Licitra, Lisa; Melichar, Bohuslav; Nicolau, Ulisses Ribaldo; Rauch, Daniel; Zanetta-Devauges, Sylvie; Cohen, Ezra E. W.; Machiels, Jean-Pascal; Tahara, Makoto; Vermorken, Jan; Geng, Yuan; Zografos, Eleftherios; Gauler, Thomas
err分享
err收藏
Results of API-AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome-09 study法国OS2006/Sarcome-09研究中包含的基于api-ai的方案在骨肉瘤成年患者中的结果
err2019-07-19
err29
errOAAI
errPiperno-Neumann, Sophie; Ray-Coquard, Isabelle; Occean, Bob-Valery; Laurence, Valerie; Cupissol, Didier; Perrin, Christophe; Penel, Nicolas; Bompas, Emmanuelle; Rios, Maria; Le Cesne, Axel; Italiano, Antoine; Anract, Philippe; de Pinieux, Gonzague; Collard, Olivier; Bertucci, Francois; Duffaud, Florence; Le Deley, Marie-Cecile; Delaye, Jessy; Brugieres, Laurence; Blay, Jean-Yves
err分享
err收藏
Cetuximab pharmacokinetic/pharmacodynamics relationships in advanced head and neck carcinoma patients
err2019-04-13
err21
errOAAI
errLe Louedec, Felicien; Alix-Panabieres, Catherine; Lafont, Thierry; Allal, Ben C.; Garrel, Renaud; Digue, Laurence; Guigay, Joel; Cupissol, Didier; Delord, Jean-Pierre; Lallemant, Benjamin; Alfonsi, Marc; Aubry, Karine; Mazel, Martine; Becher, Francois; Perriard, Francoise; Chatelut, Etienne; Thomas, Fabienne
err分享
err收藏
Treatment of patients with inoperable stage III or stage IV melanoma. Societe francaise de dermatologie
err2018-06-01
err3
PREAI
errGuillot, B.; Charles, J.; Jeudy, G.; Cupissol, D.; Dupuy, A.; Dutriaux, C.; Gangloff, D.; Magne, N.; Mirabe, X.; M'Sadek, A.; Pracht, M.; Sichel, C.; Do Outeiro, G.
err分享
err收藏
Improved survival using specialized multidisciplinary board in sarcoma patients
err2017-11-01
err245
errOAAI
errBlay, J-Y; Soibinet, P.; Penel, N.; Bompas, E.; Duffaud, F.; Stoeckle, E.; Mir, O.; Adam, J.; Chevreau, C.; Bonvalot, S.; Rios, M.; Kerbrat, P.; Cupissol, D.; Anract, P.; Gouin, F.; Kurtz, J-E; Lebbe, C.; Isambert, N.; Bertucci, F.; Toumonde, M.; Thyss, A.; Piperno-Neumann, S.; Dubray-Longeras, P.; Meeus, P.; Ducimetiere, F.; Giraud, A.; Coindre, J-M; Ray-Coquard, I.; Italiano, A.; Le Cesne, A.
err分享
err收藏
Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database
err2017-08-01
err115
errOAAI
errSalas, S.; Resseguier, N.; Blay, J. Y.; Le Cesne, A.; Italiano, A.; Chevreau, C.; Rosset, P.; Isambert, N.; Soulie, P.; Cupissol, D.; Delcambre, C.; Bay, J. O.; Dubray-Longeras, P.; Krengli, M.; De Bari, B.; Villa, S.; Kaanders, J. H. A. M.; Torrente, S.; Pasquier, D.; Thariat, J. O.; Myroslav, L.; Sole, C. V.; Dincbas, H. F.; Habboush, J. Y.; Zilli, T.; Dragan, T.; Khanfir, K.; Ugurluer, G.; Cena, T.; Duffaud, F.; Penel, N.; Bertucci, F.; Ranchere-Vince, D.; Terrier, P.; Bonvalot, S.; Macagno, N.; Lemoine, C.; Lae, M.; Coindre, J. M.; Bouvier, C.
err分享
err收藏